NHS Scotland Diabetic Retinopathy Screening Collaborative Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT03439345
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

NHS Scotland Diabetic Retinopathy Screening Collaborative

Active Ingredients

Drugs in Phase 4 Trials (1)

fenofibrate (fenoglide) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Retinopathy (Phase 4)

Retinal Diseases (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1